Matches in Nanopublications for { ?s ?p "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.
- assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP239259.RAUepDlVgEDAmYo0eiv7Jq2fU38au6aGB4dXn4RPkHB0w130_assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239259.RAUepDlVgEDAmYo0eiv7Jq2fU38au6aGB4dXn4RPkHB0w130_provenance.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.